TPG Capital’s Majority Investment in Confluent Medical Technologies

Latham & Watkins represented TPG Capital in the transaction.Confluent Medical Technologies (Confluent), a leading materials science, development, and manufacturing partner to medical device manufacturers, has announced…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now